Diagnostic Indicators for Sjögren's Syndrome

Diagnostic Significance of SSB Antibodies

The American Academy of Ophthalmology recommends that anti-Sjögren syndrome B antibody (SSB or anti-La) is one of the key serological markers included in the diagnostic criteria for Sjögren's syndrome, alongside anti-Sjögren syndrome A antibody (SSA or anti-Ro), rheumatoid factor, and antinuclear antibody 1, 2
A positive SSB test alone is not sufficient for diagnosis but is a strong indicator when combined with other clinical features 3
The latest classification criteria for Sjögren's syndrome use a weighted scoring system where anti-SSA/Ro antibody positivity scores 3 points, and a total score of ≥4 meets the criteria for primary Sjögren's syndrome 3

Patients with Sjögren's syndrome often experience dry mouth symptoms, including the need for liquids to swallow dry foods, frequent sipping of water, burning sensation in mouth, and frequent dental cavities 4
Dry eye symptoms, such as sensation of dryness, irritation, foreign body sensation, and light sensitivity, are also common in Sjögren's syndrome patients 4
The American College of Rheumatology suggests that a complete serological panel, including SSA/Ro, SSB/La, rheumatoid factor, and antinuclear antibody, should be conducted as part of the diagnostic evaluation 1, 2

Patients with Sjögren's syndrome have approximately 10% risk of developing lymphoma, with decreased C4 levels at diagnosis indicating higher risk 3, 5
The American Academy of Ophthalmology recommends that management requires a multidisciplinary approach involving dental professionals, ophthalmologists, and rheumatologists, and preventive dental strategies are essential 3

The presence of anti-SSA 52kD antibodies may indicate an increased risk for developing sicca symptoms, such as dry eyes and dry mouth, in patients with Sjögren's syndrome 6, 7
Patients with a positive anti-SSA 52kD test may also be at risk for extraglandular manifestations and autoimmune cytopenia, although the specific risk factors and associations are still being researched 6, 7

A complete serological panel, including rheumatoid factor, is recommended for patients with suspected Sjögren's syndrome, as part of a comprehensive diagnostic workup 8
Ocular surface tests, such as tear film break-up time and tear meniscus height assessment, may be considered if clinical suspicion remains high, alongside salivary gland assessment and minor salivary gland biopsy if needed 6, 7, 8

HCV-related sicca syndrome can be differentiated from Sjögren's syndrome by the absence of anti-SSA/SSB antibodies, highlighting the importance of serological testing in diagnosis 6, 7

The American Academy of Ophthalmology recommends maintaining high suspicion for Sjögren's syndrome in patients with clinically significant dry eye AND dry mouth symptoms, and assessing for objective findings on examination, such as reduced tear meniscus, abnormal tear break-up time, and punctate staining 9
A complete serological panel, including anti-SSA/Ro, anti-SSB/La, rheumatoid factor (RF), and antinuclear antibody (ANA), should be ordered when Sjögren's syndrome is suspected, as anti-Ro positivity alone is insufficient for diagnosis but becomes highly significant when combined with clinical manifestations 9

Anti-Ro/SSA antibodies have prognostic value in Systemic lupus erythematosus (SLE) and are associated with neonatal lupus, with the combination of Smith antibodies with SSA antibodies being more characteristic of SLE than isolated Sjögren's syndrome 10
Checkpoint inhibitor-induced sicca syndrome can be differentiated from Sjögren's syndrome, as only 20% of patients with immunotherapy-related sicca have anti-Ro antibodies, and they show distinct histological patterns 11

In women of childbearing age, anti-Ro positivity carries a risk for neonatal lupus and congenital heart block, requiring counseling about pregnancy complications 10

The European Respiratory Review suggests that differential diagnosis considerations, such as HCV-related sicca syndrome and checkpoint inhibitor-induced sicca syndrome, should be taken into account when diagnosing Sjögren's syndrome, with HCV-related sicca syndrome differentiated by the absence of anti-SSA/SSB antibodies and checkpoint inhibitor-induced sicca syndrome showing only 20% anti-Ro positivity with distinct histological patterns 12
The presence of anti-SSA/Ro and anti-SSB/La antibodies is strongly associated with early-onset disease and a severe disease course, according to the American College of Rheumatology, with anti-Ro/SSA and anti-La/SSB antibodies lacking specificity for Sjögren's syndrome and can be present in other autoimmune conditions, particularly systemic lupus erythematosus (SLE) 12

For women of childbearing age with positive anti-Ro/SSA antibodies, the American College of Obstetricians and Gynecologists recommends counseling about the risk of neonatal lupus and congenital heart block, considering hydroxychloroquine to reduce the risk of congenital heart block in pregnant women with a history of neonatal lupus, and arranging serial fetal echocardiograms between weeks 16-26 of pregnancy 12

Antinuclear antibody (ANA) by immunofluorescence is positive in 57% of Sjögren's patients and associated with more severe disease manifestations, according to the American Thoracic Society 13
Rheumatoid factor (RF) is present in 30% of patients and correlates with extraglandular manifestations, as reported by the American Thoracic Society 13